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Dyspnea and exercise limitation are common in patients with idiopathic pulmonary arterial
hypertension (IPAH). Recently, a reduction in inspiratory and expiratory muscle strength
has been observed in IPAH. However, it has not been investigated whether this respiratory
muscle weakness might be part of a general muscle dysfunction as observed in congestive
left heart failure.
Therefore, in 24 consecutive IPAH patients (16 female; age 58.7716.2; WHO class II–III;
systolic pulmonary artery pressure during echocardiography at rest (sPAP) 65.0720.6mmHg,
and 6-min-walk test (6-MWT) 473.67127.7m), the maximal isometric forearm muscle
strength (best of three hand grip manoeuvres), maximal inspiratory and expiratory mouth
occlusion pressures (Pimax, Pemax) were prospectively evaluated.
The isometric forearm muscle strength was significantly lower in IPAH patients
(281.77102.6 N) than in matched 24 healthy controls (397.17116.8N; p ¼ 0.03). In IPAH
patients, there was a correlation between maximal isometric forearm muscle strength
and 6-MWT (r ¼ 0.67; p ¼ 0.0007) and both, Pimax (r ¼ 0.69; p ¼ 0.0003) and Pemax
(r ¼ 0.63; p ¼ 0.01), respectively. There was no correlation between forearm muscle
strength and sPAP (r ¼ 0.30; p ¼ 0.16). The present skeletal muscle dysfunction is a novel
finding in patients with IPAH. The correlation with respiratory muscle dysfunction and
severity of disease might indicate a generalised ‘‘myopathy’’ in IPAH.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Idiopathic pulmonary arterial hypertension (IPAH) is defined
as a pulmonary vasculopathy of unknown aetiology.1 It is
characterised by dyspnoea and exercise limitation eventually
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weakness of the in- and expiratory musculature has been
described in patients with IPAH.4 In the accompanying
editorial, Naeije called attention to pulmonary hypertension
as a ‘‘systemic disease’’, where a general myopathy might
occur, in analogy to observations in congestive left heart
failure heart.5,6–11 However, the function of the peripheral
skeletal musculature has not been investigated in patients
with IPAH so far.
Therefore, the present study evaluates the strength of
the forearm musculature, in relation to respiratory muscle
function and to severity of disease in patients with IPAH.
Material and methods
Patients
This prospective study included 24 patients (Table 1) with
the diagnosis of IPAH made according to present guide-
lines,12 including right heart catheterization: the systolic
pulmonary artery pressure (sPAP) was 78.1723.7mmHg, the
mean pulmonary artery pressure was 47.9713.5mmHg; the
pulmonary vascular resistance was 867.67476.1 dyn s cm5,
and the cardiac output was 4.271.3 Lmin1. Eight patients
were in WHO functional class II, 16 patients in class III.
Patients included in the study showed no clinical or
radiological signs of cardiopulmonary decompensation. By
definition, concomitant left heart disease or other pulmon-
ary disease was excluded.
Approval from the local ethics committee was obtained.
Patients gave written informed consent.
Forearm muscle function testing
The maximal isometric forearm muscle strength of the
dominant arm was assessed in standing position by a hand
grip dynamometer. The hand grip dynamometer was held
along the axis of the arm in a comfortable position.
Maximum forearm muscle strength was assessed according
to the assessment of the one-repetition-maximum.13 Briefly,
after familiarisation with the measurement device and
procedure, subjects performed at least three attempts of
maximal voluntary ‘‘hand grip’’ contraction against the
dynamometer separated by a resting period of at least
3min. If muscle strength was still increasing after the third
attempt, they had additional attempts until muscle strength
decreased. The maximum number in the present study wasTable 1 Characteristics of patients with idiopathic pulmonary
IPAH n ¼ 24
Male 8
Female 16
Age (years) 58.7716.2
Height (cm) 165.978.3
Body mass index (kgm2) 27.776.5
Fore arm strength (N) 281.77102.6
Systolic PAP echo (mmHg) 65.0720.6
PAP ¼ pulmonary artery pressure; ns ¼ not significant.five attempts. The best of all hand grip manoeuvres was
analysed as maximal forearm muscle strength in Newton
(N ¼ 1 kgm s2).
Since reference values for forearm muscle strength are
lacking, 24 matched controls were included in the study.
Age, height, weight, body mass index, gender proportion did
not differ between the patient group and the controls.Respiratory muscle function testing
Mouth pressures were determined as described pre-
viously4,5,14 with the patients sitting upright and breathing
through a flanged mouthpiece inside the lips (Jaeger-Viasys
Healthcare; MasterLabPro 4.2; Wuerzburg; Germany).15,16 In
brief, maximal inspiratory pressure (Pimax) was determined
during a deep inspiration from functional residual capacity
against a shutter with a minor air leak preventing undesir-
able glottis closure. Pimax is a negative pressure, but is
expressed as a positive value. Maximal expiratory pressure
(Pemax) was measured during maximal expiratory effort at
total lung capacity. Pimax and Pemax were determined from
the best of five consecutive manoeuvres (varying o20%).Six-min-walk test (6-MWT)
The 6-MWT was performed according to American Thoracic
Society guidelines.17Echocardiography
Patients underwent routine transthoracic echocardiography
using commercially available equipment (Vivid 7, GE
Vingmed Ultrasound, Horten, Norway) with a 3.5MHz
transducer. The tricuspid inflow velocity was measured in
the apical four-chamber view using continuous-wave Dop-
pler. The sample volume was positioned at the tips of
tricuspid leaflets. sPAP was estimated as a sum of the
pressure difference across the tricuspid valve calculated
using the Bernoulli equation and RAP, since there was no
evidence of pulmonary valve stenosis. Sweep speed used in
all Doppler recordings was 100mm/s. Five consecutive beats
were recorded and averaged for each measurement. The
investigator was unaware of the results in the 6-MWT or
muscle testing.hypertension and in controls.
Controls n ¼ 24 p-Value
8 ns
16 ns
57.6714.2 ns
171.2716.0 ns
24.572.6 ns
397.17116.8 0.03
–
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Figure 2 Dependence of maximal static lower arm muscula-
ture strength (‘‘hand grip’’) and 6-min-walk test in 24 IPAH
patients.
R. Bauer et al.2368Data analysis
All results are expressed as means7standard deviation.
Unpaired Student’s t-test and linear regression analysis were
used as appropriate.18 A level of po0.05 was accepted as
statistically significant.
Results
Function of the skeletal and respiratory
musculature
In patients with IPAH, the maximal isometric forearm muscle
strength (hand grip) was significantly lower than in healthy
controls (281.77102.6 vs. 397.17116.8 N, respectively;
p ¼ 0.03). This finding indicates peripheral skeletal muscle
dysfunction in patients with IPAH.
Moreover in IPAH patients, there was a linear correlation
between hand grip strength and both maximal mouth
occlusion pressures: Pimax (Fig. 1) and Pemax (r ¼ 0.63;
p ¼ 0.01), respectively.
Muscle function and severity of disease
There was a significant correlation between the maximal
isometric forearm muscle strength and the functional
severity of disease, assessed by the 6-MWT (Fig. 2).
The changes in hand grip strength were not significantly
related to sPAP (r ¼ 0.30; p ¼ 0.16).
Discussion
The present study provides first evidence of skeletal muscle
dysfunction in IPAH:
(1) the maximal isometric forearm muscle strength
(‘‘hand grip’’) in patients with IPAH is significantly reduced
as compared with respective controls; (2) the reduction in
skeletal muscle strength is paralleled by an inspiratory and
expiratory muscle dysfunction; (3) skeletal muscle weakness
is closely related to clinical severity of disease, as assessed
by the 6-MWT.0
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Figure 1 Significant correlation between maximal static lower
arm musculature strength (‘‘hand grip’’) and the maximal
inspiratory mouth occlusion pressure in 24 patients with IPAH.The maximal isometric forearm muscle strength depends
on age, gender and body mass index.19–21 Since reference
values are scarce, matched healthy controls were included
in the present study.
The parallel reduction in both, the peripheral skeletal and
the respiratory muscle strength in the present IPAH patients
might indicate a generalised systemic muscle weakness
syndrome, in analogy to observations in patients with
congestive left heart failure.8–10 Consequently one might
speculate, that the cardiac output limitation in IPAH could
lead to continuously activated sympathetic nervous system,
together with reflexes of metabaro- and ergo-receptors, as
seen in congestive heart failure, and recently in pulmonary
hypertension.8,22
Moreover in congestive left heart failure and in chronic
obstructive airway disease (COPD), skeletal and respiratory
muscle weakness has been attributed to the impaired
muscle perfusion and reduced peripheral oxygen delivery.
As a consequence, deconditioning, changes in muscle
fibre composition towards type IIb-fibres, abnormal intra-
cellular calcium profiles, muscle bulk atrophy and the
clinical state of wasting or cachexia have been described
in experimental and clinical studies in congestive left heart
failure.9–11,23
The present findings indicate that the peripheral skeletal
muscle weakness might contribute to the exercise limita-
tion, i.e. 6-MWT. However, hand grip strength was indepen-
dent from haemodynamics. This is in accordance with
previous findings in pulmonary hypertension, where the
patients’ functional status and prognosis were more
significantly correlated to walk distances than to haemody-
namics.24 Moreover, the close relation between peripheral
muscle function and 6-MWT is paralleled by recent findings
in COPD patients.25
Since pronounced exercise limitation is a major disabling
symptom in IPAH patients, and it is closely correlated to
peripheral skeletal muscle weakness in the present study,
future investigations should aim to identify therapeutic
interventions capable to improve the skeletal muscle
dysfunction.
So far in congestive left heart failure, exercise training
has been shown to improve exercise tolerance.9 A recent
interventional study in patients with IPAH, demonstrated a
significant improvement in exercise tolerance.26 However,
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respiratory muscle function explicitly.
The assessment of peripheral skeletal and respiratory
muscle dysfunction is relatively simple and also feasible
during routine out-patient evaluation. Therefore, ‘‘hand
grip strength’’ and maximal mouth occlusion pressures
should be evaluated for their potential role as non-invasive
therapy monitoring tool or for risk stratification, since two
studies in patents with congestive left heart failure, have
characterized Pimax as a significant and independent prog-
nostic marker.6,7
Clinical implication and conclusion
The present skeletal muscle dysfunction is a novel finding in
IPAH. It is related to respiratory muscle weakness and to
clinical severity of disease, suggesting the presence of a
‘‘generalised myopathy’’ in patients with IPAH. The under-
lying pathomechanisms and the therapeutic options to
improve this generalised muscle weakness should be further
investigated.
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